ReviewCancers2023
Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials.
Shigeto Nishikawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
70 papers cite itlatest 60 shown
this paperpooled itcites it
ReviewCancers2023
Shigeto Nishikawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.